High level expression and secretion of Fc-X fusion proteins in mammalian cells

被引:76
作者
Lo, KM [1 ]
Sudo, Y [1 ]
Chen, J [1 ]
Li, Y [1 ]
Lan, Y [1 ]
Kong, SM [1 ]
Chen, LL [1 ]
An, Q [1 ]
Gillies, SD [1 ]
机构
[1] Lexigen Pharmaceut Corp, Lexington, MA 02173 USA
来源
PROTEIN ENGINEERING | 1998年 / 11卷 / 06期
关键词
expression; Fc; Fc-X; fusion protein;
D O I
10.1093/protein/11.6.495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a general expression system that enhances the production and secretion of proteins in mammalian cells, The protein of interest is expressed as a fusion to a signal peptide and the Fc fragment of immunoglobulin as the N-terminal fusion partner, which can direct the cellular processes into expressing and secreting high levels of many different types of proteins. These include secretory proteins, enzymes and soluble domains of membrane proteins, as well as nuclear and regulatory proteins. Typical expression levels of these proteins from stable cell lines ranged from several to 100 mu g/ml in conditioned media. The Fc domain helps to solubilize hydrophobic proteins and provides a handle for easy detection and purification of the fusion proteins; and it can be cleaved off by treatment with protease if desired.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 20 条
[1]   COMPLEMENTARY-DNA SEQUENCING - EXPRESSED SEQUENCE TAGS AND HUMAN GENOME PROJECT [J].
ADAMS, MD ;
KELLEY, JM ;
GOCAYNE, JD ;
DUBNICK, M ;
POLYMEROPOULOS, MH ;
XIAO, H ;
MERRIL, CR ;
WU, A ;
OLDE, B ;
MORENO, RF ;
KERLAVAGE, AR ;
MCCOMBIE, WR ;
VENTER, JC .
SCIENCE, 1991, 252 (5013) :1651-1656
[2]   DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY [J].
CAPON, DJ ;
CHAMOW, SM ;
MORDENTI, J ;
MARSTERS, SA ;
GREGORY, T ;
MITSUYA, H ;
BYRN, RA ;
LUCAS, C ;
WURM, FM ;
GROOPMAN, JE ;
BRODER, S ;
SMITH, DH .
NATURE, 1989, 337 (6207) :525-531
[3]   Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase [J].
Carter, RE ;
Feldman, AR ;
Coyle, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :749-753
[4]   A RECOMBINANT IMMUNOTOXIN CONSISTING OF 2 ANTIBODY VARIABLE DOMAINS FUSED TO PSEUDOMONAS EXOTOXIN [J].
CHAUDHARY, VK ;
QUEEN, C ;
JUNGHANS, RP ;
WALDMANN, TA ;
FITZGERALD, DJ ;
PASTAN, I .
NATURE, 1989, 339 (6223) :394-397
[5]   BLOOD-BRAIN-BARRIER PENETRATION AND INVIVO ACTIVITY OF AN NGF CONJUGATE [J].
FRIDEN, PM ;
WALUS, LR ;
WATSON, P ;
DOCTROW, SR ;
KOZARICH, JW ;
BACKMAN, C ;
BERGMAN, H ;
HOFFER, B ;
BLOOM, F ;
GRANHOLM, AC .
SCIENCE, 1993, 259 (5093) :373-377
[6]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550
[7]   BIOLOGICAL-ACTIVITY AND INVIVO CLEARANCE OF ANTITUMOR ANTIBODY/CYTOKINE FUSION PROTEINS [J].
GILLIES, SD ;
YOUNG, D ;
LO, KM ;
ROBERTS, S .
BIOCONJUGATE CHEMISTRY, 1993, 4 (03) :230-235
[8]   ANTIBODY-TARGETED INTERLEUKIN-2 STIMULATES T-CELL KILLING OF AUTOLOGOUS TUMOR-CELLS [J].
GILLIES, SD ;
REILLY, EB ;
LO, KM ;
REISFELD, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) :1428-1432
[9]   HIGH-LEVEL EXPRESSION OF CHIMERIC ANTIBODIES USING ADAPTED CDNA VARIABLE REGION CASSETTES [J].
GILLIES, SD ;
LO, KM ;
WESOLOWSKI, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 125 (1-2) :191-202
[10]   A SHORT POLYPEPTIDE MARKER SEQUENCE USEFUL FOR RECOMBINANT PROTEIN IDENTIFICATION AND PURIFICATION [J].
HOPP, TP ;
PRICKETT, KS ;
PRICE, VL ;
LIBBY, RT ;
MARCH, CJ ;
CERRETTI, DP ;
URDAL, DL ;
CONLON, PJ .
BIO-TECHNOLOGY, 1988, 6 (10) :1204-1210